Given the dominant prognostic value of lymph node metastasis, we examined the prognostic significance of p21+/P-S6+ phenotype in the subgroup of patients with no regional lymph node affection at the time of diagnosis (N0 patients). The gene discussed is RPS6; the disease is metastatic malignant neoplasm in the lymph nodes.